Dry Fasting — The Record

Pathway atlas · node 1 of 41

RTK / RAS / MAP-kinase

What fasting does to this node, by modality, by system and by grade. Disconfirming evidence is reported first.

Founder's components: EGFR, ERBB2/3/4, FGFR1-4, MET, ALK, RET, KIT, PDGFRA, KRAS/HRAS/NRAS, BRAF, RAF1, MAP2K1, ERK, NF1, SOS1, PTPN11.

DRY status

DRY: one ligand-level measurement located, no pathway measurement located. Papagiannopoulos-Vatopaidinos et al. 2020 (5-day absolute dry fast, n=10) measured no RTK, RAS or MAPK component. Al lami et al. 2024 (30-day dawn-to-dusk dry fast) measured circulating FGF2, a ligand for FGFR1-4, which are components on the founder's own list: FGF2 DECREASED, p = 0.010. That is a ligand, not pathway activity, and it is the entire DRY evidence for this node. Queries run for DRY on this node: "dry fasting humans study metabolic markers Filonov absolute dry fast research"; "dry fasting intermittent 16 hours no water Ramadan dehydration hormone IGF-1 study"; "'dry fasting' study humans peer reviewed trial outcomes 2024 2025 systematic review"; Russian "сухое голодание исследование Филонов метаболизм результаты". No DRY study measuring EGFR, RAS, RAF, MEK or ERK was located in any language channel.

Disconfirming, nulls and contradictions first

Graded rows

#ModalitySystemTierGradeFindingSource
1.1DRYHuman, 30-day dawn-to-dusk dry fast, increased BMIH3CCirculating FGF2 decreased, p = 0.010. Ligand for FGFR1-4. No receptor or kinase measured. Single-arm observational.Al lami et al. 2024, Metabolism Open 21:100274, PMID 38455231, DOI 10.1016/j.metop.2024.100274
1.2PF (36 h)Human PBMC, n=10H3CEGFR ligands AREG +2.31, HBEGF +2.57 at nominal p<0.05. No gene survived FDR<5%. No receptor or kinase measured.Elliott et al. 2014, Genes Nutr 9:432, DOI 10.1007/s12263-014-0432-4
1.3PF (48 h)Mouse small intestine, Lgr5-EGFP, NT wild-type vs knockoutA1CNeurotensin stimulated ERK1/2 signaling when nutrients were available; during nutrient depletion the NT-dependent signal was WNT/beta-catenin, not ERK.Rock et al. 2021, Cell Mol Gastroenterol Hepatol 13(2):501-516, PMID 34560309, DOI 10.1016/j.jcmgh.2021.09.006
1.4none (no fasting tested)Mouse intestine, HIF-2alpha gain and loss of functionMCIntestinal HIF-2alpha potentiates fatty-acid-induced GLP-1 secretion through ERK signaling. No fasting intervention was run. Link to fasting is inferred only through node 10.Mooli et al. 2021, Cell Mol Gastroenterol Hepatol 13(4):1057-1072, PMID 34902628, DOI 10.1016/j.jcmgh.2021.12.004

Open questions


All 41 nodes 2. PI3K / AKT / mTOR →


dryfasting.com has been published since 2014. This evidence record was compiled on 22 November 2026. Every row names the fasting modality the study actually ran, the system it was measured in and the grade. Where no source carries a DOI or PMID the row says so rather than supplying one. Nothing is sold on this site.